- Home
- ATRA vs CULP Comparison
ATRA vs CULP Comparison
Compare ATRA & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRA | CULP |
|---|---|---|
| Founded | 2012 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 43.8M |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ATRA | CULP |
|---|---|---|
| Price | $9.82 | $3.34 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 96.4K | 23.2K |
| Earning Date | 05-13-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.52 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $120,772,000.00 | ★ $213,237,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $2.70 |
| 52 Week High | $19.15 | $4.75 |
Technical Indicators
Market Signals| Indicator | ATRA | CULP |
|---|---|---|
| Relative Strength Index (RSI) | 54.32 | 49.43 |
| Support Level | $9.35 | $2.71 |
| Resistance Level | $11.35 | $3.19 |
| Average True Range (ATR) | 0.75 | 0.16 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 27.30 | 45.83 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.